News
The Scottish government is investing £11 million into the Glasgow-based Industrial Biotechnology Innovation Centre (IBioIC), an innovation centre...
The FDA have announced a plan to crack down on the so-called ‘e-cig epidemic’, following revelations that vaping and use of e-cigarettes has become...
Gene and cell therapy group Oxford Biomedica has announced plans to expand its business with a new site located not far from its headquarters based...
Novartis has revealed data from a range of multinational, real-world studies which reinforced the efficacy of its interleukin-17A inhibitor Cosentyx...
Celgene has revealed that Otezla (apremilast) achieved “meaningful improvements” in outcomes of patients with moderate to severe plaque psoriasis...
Phase 3 data presents strong case for switching from Humira to Janssen's Tremfya in plaque psoriasis
Janssen has unveiled new Phase 3 data derived from two separate trials on the efficacy and benefits of switching to its Interleukin-23 (IL-23)-...
Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its Shire Plc acquisition...
Bavencio combined with Inlyta has shown strong results in a Phase 3 trial investigating its efficacy as a first-line therapy for patients with...
Bristol-Myers Squibb has unveiled new Phase 2 data for its investigational oral, selective tyrosine kinase 2 (TYK2) inhibitor, known as BMS-986165...
Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and could save hundreds...
